193 related articles for article (PubMed ID: 30422238)
1. Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene.
Cabello I; Alia P; Pintó X; Muniesa C; Fernandez-de-Misa R; Peñate Y; Morillo M; Perez-Farriols A; Estrach T; Izu R; Gallardo F; Román C; Cervigón I; Ortiz-Brugues A; Ortiz-Romero PL; Servitje O
JAMA Dermatol; 2018 Dec; 154(12):1424-1431. PubMed ID: 30422238
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
3. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
[TBL] [Abstract][Full Text] [Related]
4. Investigation of associations between apolipoprotein A5 and C3 gene polymorphisms with plasma triglyceride and lipid levels.
Taşkin E; Bağci H; Turan MK
Rev Assoc Med Bras (1992); 2023; 69(3):415-420. PubMed ID: 36921196
[TBL] [Abstract][Full Text] [Related]
5. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
6. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
7. The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.
Henneman P; van der Sman-de Beer F; Moghaddam PH; Huijts P; Stalenhoef AF; Kastelein JJ; van Duijn CM; Havekes LM; Frants RR; van Dijk KW; Smelt AH
Eur J Hum Genet; 2009 May; 17(5):620-8. PubMed ID: 19034316
[TBL] [Abstract][Full Text] [Related]
8. Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy.
Bautista-Martínez JS; Mata-Marín JA; Sandoval-Ramírez JL; Chaparro-Sánchez A; Manjarrez-Téllez B; Uribe-Noguez LA; Gaytán-Martínez J; Núñez-Armendáriz M; Cruz-Sánchez A; Núñez-Rodríguez N; Iván MA; Morales-González GS; Álvarez-Mendoza JP; Pérez-Barragán E; Ríos-De Los Ríos J; Contreras-Chávez GG; Tapia-Magallanes DM; Ribas-Aparicio RM; Díaz-López M; Olivares-Labastida A; Gómez-Delgado A; Torres J; Miranda-Duarte A; Zenteno JC; Pompa-Mera EN
Pharmacogenet Genomics; 2022 Apr; 32(3):101-110. PubMed ID: 34693928
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of triglyceride and triglyceride-rich lipoprotein triglyceride induced by a high-carbohydrate diet is associated with polymorphisms of APOA5-1131T>C and APOC3-482C>T in Chinese healthy young adults.
Lin J; Fang DZ; Du J; Shigdar S; Xiao LY; Zhou XD; Duan W
Ann Nutr Metab; 2011; 58(2):150-7. PubMed ID: 21646779
[TBL] [Abstract][Full Text] [Related]
10. Alcohol, Carbohydrate, and Calcium Intakes and Smoking Interactions with APOA5 rs662799 and rs2266788 were Associated with Elevated Plasma Triglyceride Concentrations in a Cross-Sectional Study of Korean Adults.
Park S; Kang S
J Acad Nutr Diet; 2020 Aug; 120(8):1318-1329.e1. PubMed ID: 32335043
[TBL] [Abstract][Full Text] [Related]
11. Bexarotene in cutaneous T-cell lymphoma: third retrospective study of long-term cohort and review of the literature.
Quéreux G; Saint-Jean M; Peuvrel L; Brocard A; Knol AC; Dréno B
Expert Opin Pharmacother; 2013 Sep; 14(13):1711-21. PubMed ID: 23837676
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids as adjunctive treatment for bexarotene-induced hypertriglyceridaemia in patients with cutaneous T-cell lymphoma.
Cabello I; Servitje O; Corbella X; Bardés I; Pintó X
Clin Exp Dermatol; 2017 Apr; 42(3):276-281. PubMed ID: 28233333
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
14. Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients.
Charriere S; Bernard S; Aqallal M; Merlin M; Billon S; Perrot L; Le Coquil E; Sassolas A; Moulin P; Marcais C
Clin Chim Acta; 2008 Aug; 394(1-2):99-103. PubMed ID: 18468520
[TBL] [Abstract][Full Text] [Related]
15. The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.
Cabré A; Lázaro I; Girona J; Manzanares JM; Marimón F; Plana N; Guardiola M; Heras M; Masana L
Nutr Metab Cardiovasc Dis; 2010 May; 20(4):243-8. PubMed ID: 19765959
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of bexarotene combined with photo(chemo)therapy for cutaneous T-cell lymphoma.
Morita A; Tateishi C; Muramatsu S; Kubo R; Yonezawa E; Kato H; Nishida E; Tsuruta D
J Dermatol; 2020 May; 47(5):443-451. PubMed ID: 32189402
[TBL] [Abstract][Full Text] [Related]
17. APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese.
Chien KL; Fang WH; Wen HC; Lin HP; Lin YL; Lin SW; Wu JH; Kao JT
Clin Chim Acta; 2008 Apr; 390(1-2):56-62. PubMed ID: 18206649
[TBL] [Abstract][Full Text] [Related]
18. Impact of body mass index on the severity of bexarotene-associated hypertriglyceridemia: A post hoc analysis of an open-labeled clinical study of combined bexarotene and phototherapy in Japanese patients with cutaneous T-cell lymphoma.
Sanagawa A; Hayakawa T; Nishida E; Yamamoto A; Ikumi K; Mori Y; Hotta Y; Kimura K; Furukawa-Hibi Y; Morita A
J Dermatol; 2023 Jul; 50(7):917-926. PubMed ID: 37041679
[TBL] [Abstract][Full Text] [Related]
19. A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients.
Kim M; Kim M; Yoo HJ; Lee E; Chae JS; Lee SH; Lee JH
PLoS One; 2017; 12(12):e0186693. PubMed ID: 29211729
[TBL] [Abstract][Full Text] [Related]
20. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
